Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson | Lima | Healthcare | Pharmaceuticals | PEN 1.46T | 10.3x | 0.11 | PEN 555.31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Merck | Lima | Healthcare | Pharmaceuticals | PEN 1.19T | 138.4x | -1.67 | PEN 493.17 | 11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Pfizer | Lima | Healthcare | Pharmaceuticals | PEN 653.59B | -559.1x | 5.86 | PEN 114.56 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Bristol Myers Squibb | Lima | Healthcare | Pharmaceuticals | PEN 382.33B | -16.8x | 0.07 | PEN 170.43 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |
Gilead Sciences | Lima | Healthcare | Pharmaceuticals | PEN 364.84B | 198.5x | -2.04 | PEN 264.21 | -8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |